Chelsea Therapeutics, Inc. 2Q Loss Narrows on Gain

AP -- Chelsea Therapeutics International Ltd., which is developing a drug candidate to treat low blood pressure, said Wednesday its loss narrowed on a gain from prior impairments on auction-rate securities.
MORE ON THIS TOPIC